The discovery of captopril: a reply.
Smith
Charles G
CG
Vane
John R
JR
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000191:economics / Q000266:history* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000191:economics / Q000266:history* / Q000627:therapeutic use; D002216:Captopril / Q000191:economics / Q000266:history* / Q000627:therapeutic use; D004345:Drug Industry / Q000191:economics / Q000266:history; D035082:Federal Government; D049673:History, 20th Century; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D012084:Renin-Angiotensin System; D012108:Research Personnel / Q000191:economics / Q000266:history*; D012109:Research Support as Topic; D014481:United States; D014486:United States Food and Drug Administration
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002216:Captopril